Cornelis J. H. Van De Velde
#116,828
Most Influential Person Now
Cornelis J. H. Van De Velde's AcademicInfluence.com Rankings
Cornelis J. H. Van De Veldemedical Degrees
Medical
#1693
World Rank
#2059
Historical Rank
Surgery
#126
World Rank
#169
Historical Rank
Cornelis J. H. Van De Veldephilosophy Degrees
Philosophy
#5115
World Rank
#7841
Historical Rank
Logic
#2446
World Rank
#3439
Historical Rank
Download Badge
Medical Philosophy
Cornelis J. H. Van De Velde's Degrees
- Doctorate Medicine Leiden University
- PhD Surgery Leiden University
Why Is Cornelis J. H. Van De Velde Influential?
(Suggest an Edit or Addition)Cornelis J. H. Van De Velde's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. (2006) (5216)
- Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. (2001) (1980)
- Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. (2010) (1458)
- Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. (2011) (1430)
- Extended lymph-node dissection for gastric cancer. (1999) (1311)
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. (2012) (1300)
- Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. (2014) (1209)
- The TME Trial After a Median Follow-up of 6 Years: Increased Local Control But No Survival Benefit in Irradiated Patients With Resectable Rectal Carcinoma (2007) (1085)
- Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. (2001) (1035)
- Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study. (2005) (837)
- Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. (2004) (806)
- Circumferential Margin Involvement Is Still an Important Predictor of Local Recurrence in Rectal Carcinoma: Not One Millimeter but Two Millimeters Is the Limit (2002) (758)
- The clinical use of indocyanine green as a near‐infrared fluorescent contrast agent for image‐guided oncologic surgery (2011) (684)
- Micrometastases and survival in stage II colorectal cancer. (1998) (617)
- Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials (2018) (614)
- Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. (2005) (599)
- Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. (2002) (579)
- Genome-wide cell-free DNA fragmentation in patients with cancer (2019) (541)
- Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. (1993) (537)
- Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. (2011) (492)
- Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data. (2015) (429)
- Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. (2020) (419)
- EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. (2014) (395)
- Global cancer surgery: delivering safe, affordable, and timely cancer surgery. (2015) (383)
- Gastric cancer: epidemiology, pathology and treatment. (2003) (375)
- No downstaging after short-term preoperative radiotherapy in rectal cancer patients. (2001) (355)
- Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. (2018) (334)
- The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. (1991) (329)
- In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild‐type p53 (1993) (296)
- Imaging for predicting the risk factors--the circumferential resection margin and nodal disease--of local recurrence in rectal cancer: a meta-analysis. (2005) (291)
- Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial. (2015) (278)
- Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. (2010) (277)
- A multivariate analysis of limiting factors for stoma reversal in patients with rectal cancer entered into the total mesorectal excision (TME) trial: a retrospective study. (2007) (269)
- Optical Image-guided Surgery—Where Do We Stand? (2010) (266)
- Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial (2013) (263)
- Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. (1995) (257)
- Controversies of total mesorectal excision for rectal cancer in elderly patients. (2008) (254)
- Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group. (1999) (252)
- Policy statement on multidisciplinary cancer care. (2014) (249)
- Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. (2014) (243)
- HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients (2010) (242)
- Near‐infrared fluorescence‐guided resection of colorectal liver metastases (2013) (236)
- Toward Optimization of Imaging System and Lymphatic Tracer for Near-Infrared Fluorescent Sentinel Lymph Node Mapping in Breast Cancer (2011) (235)
- Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS Trial (2010) (233)
- EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. (2004) (232)
- Risk factors for sexual dysfunction after rectal cancer treatment. (2009) (227)
- Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. (2010) (226)
- Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer. (2019) (222)
- Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. (2010) (210)
- Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS) (2011) (205)
- Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial. (2015) (203)
- Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials (2019) (197)
- Radical and nerve‐preserving surgery for rectal cancer in the Netherlands: a prospective study on morbidity and functional outcome (1998) (194)
- Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands. (1998) (191)
- Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. (2012) (186)
- p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer. (1998) (181)
- Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. (1994) (181)
- Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. (2004) (178)
- Prognostic Value of Tumor-Infiltrating Dendritic Cells in Colorectal Cancer: Role of Maturation Status and Intratumoral Localization (2005) (177)
- Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. (2000) (177)
- The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. (2009) (177)
- A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer (2016) (173)
- Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. (2010) (173)
- Unmet needs and challenges in gastric cancer: the way forward. (2014) (168)
- Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial. (2011) (163)
- Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer (2009) (157)
- USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria. (2008) (155)
- Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy. (2004) (152)
- Improved diagnosis and treatment of anastomotic leakage after colorectal surgery. (2009) (148)
- Local recurrence after breast conservation therapy for early stage breast carcinoma (1999) (146)
- Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study (2001) (145)
- Antibodies against p53 are associated with poor prognosis of colorectal cancer. (1995) (145)
- Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data. (2013) (143)
- Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009. (2012) (143)
- Risk Factors for Adverse Outcome in Patients With Rectal Cancer Treated With an Abdominoperineal Resection in the Total Mesorectal Excision Trial (2007) (142)
- Intraoperative near infrared fluorescence guided identification of the ureters using low dose methylene blue: a first in human experience. (2013) (141)
- Identification of virilizing adrenal tumors in hirsute women. (1994) (138)
- Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases. (2002) (137)
- Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer (2006) (133)
- Lymph Node Retrieval in Rectal Cancer is Dependent on Many Factors—the Role of the Tumor, the Patient, the Surgeon, the Radiotherapist, and the Pathologist (2009) (132)
- Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patients (1987) (129)
- Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes? (2009) (126)
- Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. (2012) (124)
- Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: Final analysis of the EORTC AMAROS trial (10981/22023). (2013) (123)
- Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study. (1994) (122)
- Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05) (2018) (119)
- High‐resolution MALDI‐FT‐ICR MS imaging for the analysis of metabolites from formalin‐fixed, paraffin‐embedded clinical tissue samples (2015) (117)
- Natural killer cells infiltrating colorectal cancer and MHC class I expression. (2005) (115)
- Randomized Comparison of Near-infrared Fluorescence Imaging Using Indocyanine Green and 99m Technetium With or Without Patent Blue for the Sentinel Lymph Node Procedure in Breast Cancer Patients (2012) (114)
- Estimation and Prediction in a Multi‐State Model for Breast Cancer (2006) (113)
- Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study. (2018) (112)
- Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. (2014) (111)
- A Tumor-specific Kinase Activity Regulates the Viral Death Protein Apoptin* (2002) (111)
- The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer (2010) (111)
- Sentinel lymph node biopsy in breast cancer. (2002) (109)
- Real-time intraoperative detection of breast cancer using near-infrared fluorescence imaging and Methylene Blue. (2014) (109)
- Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy. (2019) (109)
- NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study (2012) (108)
- The Value of Intraoperative Near-Infrared Fluorescence Imaging Based on Enhanced Permeability and Retention of Indocyanine Green: Feasibility and False-Positives in Ovarian Cancer (2015) (108)
- Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17 (2016) (107)
- Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial. (2020) (107)
- Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG). (1999) (106)
- Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients. (2013) (105)
- PIK3CA Mutations Predict Local Recurrences in Rectal Cancer Patients (2009) (104)
- Risk Factors for Excess Mortality in the First Year After Curative Surgery for Colorectal Cancer (2012) (104)
- Heterogeneous HER2 gene amplification: impact on patient outcome and a clinically relevant definition. (2011) (102)
- EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer (2016) (101)
- Superoxide dismutases in relation to the overall survival of colorectal cancer patients. (1998) (101)
- Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer (2006) (101)
- Detection of colorectal cancer using MALDI-TOF serum protein profiling. (2006) (101)
- Optimal locoregional treatment in gastric cancer. (2005) (98)
- Induction of p53-specific immune responses in colorectal cancer patients receiving a recombinant ALVAC-p53 candidate vaccine. (2002) (97)
- Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study. (2014) (96)
- Prognostic value of resection-line involvement in patients undergoing curative resections for gastric cancer. (1996) (96)
- Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy. (2008) (96)
- Biomarkers in precision therapy in colorectal cancer (2013) (95)
- Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer. (2014) (94)
- A prospective study on radical and nerve-preserving surgery for rectal cancer in the Netherlands. (2000) (93)
- Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent (2018) (93)
- Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902 (2009) (90)
- EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe. (2013) (90)
- Optimization of near-infrared fluorescent sentinel lymph node mapping for vulvar cancer. (2012) (89)
- Validation of a nomogram for predicting disease‐specific survival after an R0 resection for gastric carcinoma (2005) (88)
- Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastases. (2010) (86)
- Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer (2005) (85)
- Effects of Acetone, Methanol, or Paraformaldehyde on Cellular Structure, Visualized by Reflection Contrast Microscopy and Transmission and Scanning Electron Microscopy (2001) (85)
- Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients. (2016) (85)
- Evaluation of the extent of lymphadenectomy in a randomized trial of Western- versus Japanese-type surgery in gastric cancer. (1994) (84)
- Lymph node retrieval in a randomized trial on western-type versus Japanese-type surgery in gastric cancer. (1996) (84)
- Clinical Implications of CYP2D6 Genotyping in Tamoxifen Treatment for Breast Cancer (2009) (84)
- EURECCA consensus conference highlights about colon & rectal cancer multidisciplinary management: the radiology experts review. (2014) (84)
- No Increased Risk of Second Cancer After Radiotherapy in Patients Treated for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials. (2015) (83)
- Superoxide dismutases in the human colorectal cancer sequence (1999) (83)
- Intraoperative guidance in parathyroid surgery using near-infrared fluorescence imaging and low-dose Methylene Blue. (2015) (83)
- Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomised trial. (2014) (82)
- The gastric cancer treatment controversy. (2003) (81)
- Short‐term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer (2002) (81)
- Lack of survival gain for elderly women with breast cancer. (2011) (81)
- Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study. (2014) (80)
- Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile (2019) (80)
- An International Collaborative Standardizing a Comprehensive Patient-Centered Outcomes Measurement Set for Colorectal Cancer (2017) (79)
- Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer. (2009) (79)
- Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study (2014) (78)
- First mature analysis of the Intergroup Exemestane Study. (2006) (78)
- Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer (2014) (78)
- Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins (2016) (78)
- Randomized comparison of near-infrared fluorescence lymphatic tracers for sentinel lymph node mapping of cervical cancer. (2012) (77)
- Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research. (2014) (77)
- Optimization of Near-Infrared Fluorescent Sentinel Lymph Node Mapping in Cervical Cancer Patients (2011) (77)
- The Prognostic Value of the Apoptosis Pathway in Colorectal Cancer: A Review of the Literature on Biomarkers Identified by Immunohistochemistry (2013) (76)
- Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients--a phase II trial. (2014) (76)
- Capecitabine, oxaliplatin, radiotherapy, and excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma: Results of an international multicenter phase II study. (2006) (75)
- Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer (2001) (74)
- Morphological Evidence of an Activated Cytotoxic T-Cell Infiltrate in EBV-Positive Gastric Carcinoma Preventing Lymph Node Metastases (2006) (74)
- Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis. (1994) (72)
- Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviour (2004) (72)
- Near-Infrared Fluorescence Imaging in Patients Undergoing Pancreaticoduodenectomy (2011) (72)
- A new paradigm for rectal cancer: Organ preservation: Introducing the International Watch & Wait Database (IWWD). (2015) (71)
- Tumor load and surgical palliation in gastric cancer. (2001) (71)
- Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver (2004) (70)
- Real-time near-infrared fluorescence guided surgery in gynecologic oncology: a review of the current state of the art. (2014) (70)
- Treatment of resectable gastric cancer (2012) (70)
- Image-guided hepatopancreatobiliary surgery using near-infrared fluorescent light (2012) (69)
- Laparoscopic detection and resection of occult liver tumors of multiple cancer types using real-time near-infrared fluorescence guidance (2016) (69)
- Experts reviews of the multidisciplinary consensus conference colon and rectal cancer 2012: science, opinions and experiences from the experts of surgery. (2014) (69)
- Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: an international tamoxifen exemestane adjuvant multinational trial analysis. (2013) (69)
- Developments and quality assurance in rectal cancer surgery. (2002) (68)
- Three-dimensional analysis of recurrence patterns in rectal cancer: the cranial border in hypofractionated preoperative radiotherapy can be lowered. (2011) (68)
- Clinical Translation of Ex Vivo Sentinel Lymph Node Mapping for Colorectal Cancer Using Invisible Near-Infrared Fluorescence Light (2010) (68)
- Isolated liver perfusion with mitomycin C in the treatment of colorectal cancer metastases confined to the liver. (1996) (68)
- EURECCA consensus conference highlights about rectal cancer clinical management: the radiation oncologist's expert review. (2014) (68)
- Improved survival after one course of perioperative chemotherapy in early breast cancer patients. long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854. (2001) (68)
- External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer. (2014) (66)
- Combinations of tumor and treatment parameters are more discriminative for prognosis than the present TNM system in rectal cancer. (2007) (66)
- Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST). (1999) (66)
- Isolated hepatic perfusion with tumor necrosis factor alpha and melphalan: experimental studies in pigs and phase I data from humans. (1998) (65)
- Status of extended lymph node dissection: Locoregional control is the only way to survive gastric cancer (2005) (64)
- Long lasting p53‐specific T cell memory responses in the absence of anti‐p53 antibodies in patients with resected primary colorectal cancer (2001) (64)
- Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner (2013) (64)
- Clinical applications of the urokinase receptor (uPAR) for cancer patients. (2011) (64)
- Preoperative Chemoradiotherapy with Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer. A Phase I–II Multicenter Study of the Dutch Colorectal Cancer Group (2007) (64)
- Patients' preferences for surgical and adjuvant systemic treatment in early breast cancer: a systematic review. (2014) (64)
- Quality control of lymph node dissection in the Dutch randomized trial of D1 and D2 lymph node dissection for gastric cancer (1998) (63)
- High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients (2014) (63)
- Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study. (2020) (63)
- Nuclear Localization of CXCR4 Determines Prognosis for Colorectal Cancer Patients (2008) (63)
- Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study. (2012) (62)
- Prognostic Value of Polycomb Proteins EZH2, BMI1 and SUZ12 and Histone Modification H3K27me3 in Colorectal Cancer (2014) (62)
- Statin Use After Diagnosis of Colon Cancer and Patient Survival. (2017) (61)
- Surgical treatment of early stage breast cancer in elderly: an international comparison (2011) (61)
- Prognostic value of the plasminogen activation system in patients with gastric carcinoma (1996) (61)
- Sentinel Lymph Node Biopsy in Vulvar Cancer Using Combined Radioactive and Fluorescence Guidance (2015) (61)
- Concordance of folate receptor-α expression between biopsy, primary tumor and metastasis in breast cancer and lung cancer patients (2016) (60)
- MAL promoter hypermethylation as a novel prognostic marker in gastric cancer (2008) (60)
- Pathology data in the central databases of multicenter randomized trials need to be based on pathology reports and controlled by trained quality managers. (2000) (59)
- T-cell based cancer immunotherapy: direct or redirected tumor-cell recognition? (1994) (59)
- Long-term follow-up after near-infrared fluorescence-guided resection of colorectal liver metastases: A retrospective multicenter analysis. (2017) (58)
- Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group (2018) (57)
- Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer. (2007) (57)
- Disrupted Expression of CXCL5 in Colorectal Cancer Is Associated with Rapid Tumor Formation in Rats and Poor Prognosis in Patients (2008) (57)
- Neoadjuvant chemotherapy in breast cancer: more than just downsizing. (2018) (57)
- Identification of potential HLA-A *0201 restricted CTL epitopes derived from the epithelial cell adhesion molecule (Ep-CAM) and the carcinoembryonic antigen (CEA). (1997) (56)
- Prognostic significance of metallothionein in human gastrointestinal cancer. (2002) (56)
- Patterns of local recurrence in locally advanced rectal cancer after intra-operative radiotherapy containing multimodality treatment. (2009) (56)
- High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers (2009) (55)
- Preclinical evaluation of a novel CEA‐targeting near‐infrared fluorescent tracer delineating colorectal and pancreatic tumors (2015) (55)
- Timing of the sentinel lymph node biopsy in breast cancer patients receiving neoadjuvant therapy - recommendations for clinical guidance. (2013) (55)
- Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study. (2012) (54)
- The New American Joint Committee on Cancer/International Union Against Cancer Staging System for Adenocarcinoma of the Stomach: Increased Complexity without Clear Improvement in Predictive Accuracy (2012) (54)
- Clinical impact of HLA class I expression in rectal cancer (2007) (52)
- Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. (1996) (52)
- Caspase-3 Activity Predicts Local Recurrence in Rectal Cancer (2007) (52)
- Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue (1992) (52)
- Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy (2014) (52)
- The Best Approach for Laparoscopic Fluorescence Cholangiography: Overview of the Literature and Optimization of Dose and Dosing Time (2017) (52)
- Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients (2014) (51)
- Real-time near-infrared fluorescence imaging using cRGD-ZW800-1 for intraoperative visualization of multiple cancer types (2017) (51)
- Addition of interferon‐α to the p53‐SLP® vaccine results in increased production of interferon‐γ in vaccinated colorectal cancer patients: A phase I/II clinical trial (2013) (51)
- Patterns of Local Recurrence in Rectal Cancer: A Single-Center Experience (2008) (51)
- Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study. (2012) (51)
- Novel Intraoperative Near-Infrared Fluorescence Camera System for Optical Image-Guided Cancer Surgery (2010) (50)
- Induction of a primary human cytotoxic T‐lymphocyte response against a novel conserved epitope in a functional sequence of HIV‐1 reverse transcriptase (1995) (50)
- Quality of surgery in T3-4 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment. Results from EORTC trial 22921. (2007) (50)
- Near-infrared fluorescence imaging of a solitary fibrous tumor of the pancreas using methylene blue. (2012) (50)
- Lymph node staging standards in gastric cancer. (1995) (49)
- The microscopic anatomy of experimental rat CC531 colon tumour metastases: Consequences for immunotherapy? (2000) (48)
- R2 compared with R1 resection for gastric cancer: morbidity and mortality in a prospective, randomised trial. (1992) (48)
- European trials with total mesorectal excision. (2000) (47)
- Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles (2005) (47)
- Near-infrared fluorescence sentinel lymph node detection in gastric cancer: A pilot study. (2016) (47)
- Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials (2011) (46)
- Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study (2014) (46)
- Factors influencing noncompliance and contamination in a randomized trial of “Western” (r1) versus “Japanese” (r2) type surgery in gastric cancer (1994) (46)
- Prognostic Value of Apoptosis in Rectal Cancer Patients of the Dutch Total Mesorectal Excision Trial: Radiotherapy Is Redundant in Intrinsically High-Apoptotic Tumors (2006) (45)
- Diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysis. (2013) (45)
- Selecting Tumor-Specific Molecular Targets in Pancreatic Adenocarcinoma: Paving the Way for Image-Guided Pancreatic Surgery (2016) (45)
- Gastric cancer: Decreasing incidence but stable survival in the Netherlands (2014) (45)
- Isolated Hepatic Perfusion with 200 mg Melphalan for Advanced Noncolorectal Liver Metastases (2008) (45)
- Quality control of surgical technique in a multicenter, prospective, randomized, controlled study on the surgical treatment of gastric cancer. (1992) (45)
- Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer. (1997) (44)
- Age-specific nonpersistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: a TEAM study analysis. (2012) (44)
- uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery (2015) (44)
- Quality assurance in the treatment of colorectal cancer: the EURECCA initiative. (2014) (44)
- The European Cancer Patient’s Bill of Rights, update and implementation 2016 (2016) (44)
- Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors. (2010) (44)
- Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis (2008) (43)
- The patient's perspective of the quality of breast cancer care. The development of an instrument to measure quality of care through focus groups and concept mapping with breast cancer patients. (2007) (43)
- Florence statement on breast cancer, 1998 forging the way ahead for more research on and better care in breast cancer. (1999) (43)
- Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: a European Society of Breast Cancer Specialists database analysis. (2015) (42)
- The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study (2011) (42)
- Influence of hospital type on outcomes after oesophageal and gastric cancer surgery (2012) (41)
- Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial. (2017) (41)
- Near-infrared fluorescence imaging of liver metastases in rats using indocyanine green. (2012) (41)
- A catalyst for change: the European cancer Patient's Bill of Rights. (2014) (41)
- Improved regional control and survival with “low Maruyama Index” surgery in gastric cancer: autopsy findings from the Dutch D1-D2 Trial (2007) (41)
- Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: identification rate and nodal outcome. (2013) (40)
- Gastric cancers of Western European and African patients show different patterns of genomic instability (2011) (40)
- Frequency and degree of aneuploidy in benign and malignant thyroid neoplasms (1990) (40)
- A comprehensive longitudinal overview of health-related quality of life and symptoms after treatment for rectal cancer in the TME trial (2016) (40)
- Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial (2000) (40)
- Expression of oncoproteins and the amount of eosinophilic and lymphocytic infiltrates can be used as prognostic factors in gastric cancer. Dutch Gastric Cancer Group (DGCG). (1996) (40)
- Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study (2017) (40)
- Characterization and Evaluation of the Artemis Camera for Fluorescence-Guided Cancer Surgery (2014) (40)
- Intraoperative fluorescence imaging to localize tumors and sentinel lymph nodes in rectal cancer (2016) (40)
- Improvement of staging by combining tumor and treatment parameters: the value for prognostication in rectal cancer. (2007) (39)
- One hundred years of curative surgery for rectal cancer: 1908-2008. (2009) (39)
- Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer (2012) (39)
- FoxP3- and CD8-positive Infiltrating Immune Cells Together Determine Clinical Outcome in Colorectal Cancer (2011) (38)
- Clinical evidence supporting genomic tests in early breast cancer: Do all genomic tests provide the same information? (2017) (38)
- The surgical approach to the adrenal gland: a comparison of the retroperitoneal and the transabdominal routes in 326 operations on 284 patients. (2000) (38)
- Aspirin Use After Diagnosis Improves Survival in Older Adults with Colon Cancer: A Retrospective Cohort Study (2012) (38)
- Overview of randomized perioperative polychemotherapy trials in women with early-stage breast cancer. (1997) (38)
- HLA-G and classical HLA class I expression in primary colorectal cancer and associated liver metastases. (2016) (38)
- Effect of glutathione depletion on inhibition of cell cycle progression and induction of apoptosis by melphalan (L-phenylalanine mustard) in human colorectal cancer cells. (1999) (38)
- Metallothionein in human gastrointestinal cancer (2000) (37)
- Magnitude and polarization of P53‐specific T‐helper immunity in connection to leukocyte infiltration of colorectal tumors (2003) (37)
- Prediction of the immunogenic potential of frameshift‐mutated antigens in microsatellite instable cancer (2008) (37)
- A new metastasizing mammary carcinoma model in mice: model characteristics and applications. (1977) (37)
- Estrogen Receptor Pathway Activity Score to Predict Clinical Response or Resistance to Neoadjuvant Endocrine Therapy in Primary Breast Cancer (2019) (37)
- Hepatic metastases in patients with colorectal cancer: relationship between size of metastases, standard of reference, and detection rates. (2002) (37)
- Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers. (2012) (37)
- Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical Trial. (2016) (36)
- Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Patients with HR+ Early-stage Breast Cancer for 10 Years of Endocrine Therapy (2020) (36)
- Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial. (2018) (35)
- Influence of surgery on outcomes in gastric cancer. (2000) (35)
- Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study (2014) (35)
- Surgical quality assurance in rectal cancer treatment: the key to improved outcome. (2005) (34)
- DNA copy number profiles of gastric cancer precursor lesions (2007) (34)
- The development of novel mouse monoclonal antibodies against the CC531 rat colon adenocarcinoma (2004) (34)
- Differences in pre-operative treatment for rectal cancer between Norway, Sweden, Denmark, Belgium and the Netherlands. (2014) (34)
- Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion. (1991) (33)
- Optical Mammography Using Diffuse Optical Spectroscopy for Monitoring Tumor Response to Neoadjuvant Chemotherapy in Women with Locally Advanced Breast Cancer (2014) (33)
- Impact of the interval between short-course radiotherapy and surgery on outcomes of rectal cancer patients. (2013) (33)
- The feasibility and reliability of sentinel node mapping in colorectal cancer. (2005) (33)
- Implementation of a short‐stay programme after breast cancer surgery (2010) (33)
- EpCAM as multi-tumour target for near-infrared fluorescence guided surgery (2016) (33)
- MicroRNA Classifier and Nomogram for Metastasis Prediction in Colon Cancer (2014) (32)
- Treatment of Melanoma Metastases Confined to the Liver and Future Perspectives (2009) (32)
- Current and Future Intraoperative Imaging Strategies to Increase Radical Resection Rates in Pancreatic Cancer Surgery (2014) (31)
- Treatment of colorectal cancer metastases confined to the liver. (1995) (31)
- The role of total mesorectal excision in the management of rectal cancer. (2002) (31)
- First Experience on Laparoscopic Near-Infrared Fluorescence Imaging of Hepatic Uveal Melanoma Metastases Using Indocyanine Green (2015) (31)
- Physical Functioning in Older Patients With Breast Cancer: A Prospective Cohort Study in the TEAM Trial. (2016) (31)
- Mixed Gastric Carcinomas Show Similar Chromosomal Aberrations in Both their Diffuse and Glandular Components (2006) (31)
- The mortality reducing effect of aspirin in colorectal cancer patients: Interpreting the evidence. (2017) (30)
- Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence. (2008) (30)
- Snapshot Study on the Value of Omentoplasty in Abdominoperineal Resection with Primary Perineal Closure for Rectal Cancer (2017) (30)
- High intrinsic apoptosis, but not radiation-induced apoptosis, predicts better survival in rectal carcinoma patients. (2003) (29)
- Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer. (2013) (29)
- Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer. (2012) (29)
- A Prospective Comparison of Younger and Older Patients' Preferences for Adjuvant Chemotherapy and Hormonal Therapy in Early Breast Cancer. (2016) (29)
- Pharmacological evaluation of experimental isolated liver perfusion and hepatic artery infusion with 5-fluorouracil. (1991) (29)
- The use of Epstein-Barr virus-transformed B lymphocyte cell lines in a peptide-reconstitution assay: identification of CEA-related HLA-A*0301-restricted potential cytotoxic T-lymphocyte epitopes. (1995) (29)
- Bispecific antibodies in cancer therapy, from the laboratory to the clinic. (1999) (29)
- Non-linear pharmacokinetics of 5-fluorouracil as described by in vivo behaviour of 5,6 dihydro-5-fluorouracil. (1986) (28)
- Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial. (2020) (28)
- Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis (2007) (28)
- Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer (2016) (28)
- Phase I/II studies of isolated hepatic perfusion with mitomycin C or melphalan in patients with colorectal cancer hepatic metastases. (1998) (28)
- Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives. (2004) (28)
- Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: a clinical and pharmacologic evaluation. (2007) (28)
- Ex vivo sentinel node mapping in colon cancer combining blue dye staining and fluorescence imaging. (2013) (27)
- Preferred and Perceived Participation of Younger and Older Patients in Decision Making About Treatment for Early Breast Cancer: A Prospective Study (2017) (27)
- Evidence of clonal divergence in colorectal carcinoma (1997) (27)
- HLA-G protein expression in colorectal cancer evaluated by immunohistochemistry and western blot analysis: Its expression characteristics remain enigmatic. (2018) (27)
- Regional administration of natural killer cells in a rat hepatic metastasis model results in better tumor infiltration and anti‐tumor response than systemic administration (1998) (27)
- Cyclin E low molecular weight isoforms occur commonly in early-onset gastric cancer and independently predict survival (2007) (27)
- Common data items in seven European oesophagogastric cancer surgery registries: towards a European upper GI cancer audit (EURECCA Upper GI). (2014) (27)
- A successful technique of in vivo isolated liver perfusion in pigs. (1986) (27)
- Effect of Hospital Volume With Respect to Performing Gastric Cancer Resection on Recurrence and Survival: Results from the CRITICS Trial. (2019) (26)
- Prediction in rectal cancer. (2012) (26)
- Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysis. (2013) (26)
- High-resolution analysis of HLA class I alterations in colorectal cancer (2006) (26)
- Intraoperative near-infrared fluorescence imaging of a paraganglioma using methylene blue: A case report (2014) (26)
- Cyclooxygenase 2 Expression in Rectal Cancer Is of Prognostic Significance in Patients Receiving Preoperative Radiotherapy (2007) (26)
- Effectiveness of isolated liver perfusion with mitomycin C in the treatment of liver tumours of rat colorectal cancer. (1991) (25)
- Preclinical uPAR-targeted multimodal imaging of locoregional oral cancer. (2017) (25)
- Disorganised stroma determined on pre‐treatment breast cancer biopsies is associated with poor response to neoadjuvant chemotherapy: Results from the NEOZOTAC trial (2015) (25)
- Epithelial Human Leukocyte Antigen-DR Expression Predicts Reduced Recurrence Rates and Prolonged Survival in Rectal Cancer Patients (2008) (25)
- Pathway-based subnetworks enable cross-disease biomarker discovery (2018) (25)
- p53 and HLA class-I expression are not down-regulated in colorectal cancer liver metastases (2004) (25)
- Introduction of a breast cancer care programme including ultra short hospital stay in 4 early adopter centres: framework for an implementation study (2007) (25)
- A comparative study of isolated liver perfusion versus hepatic artery infusion with mitomycin C in rats. (1990) (24)
- Noninvasive Detection of Metastases and Follicle Density in Ovarian Tissue Using Full-Field Optical Coherence Tomography (2016) (24)
- Electron microscopic observations on the accumulation of large granular lymphocytes (pit cells) and kupffer cells in the liver of rats treated with continuous infusion of interleukin‐2 (1990) (24)
- Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging (1999) (24)
- Adjuvant chemotherapy and relative survival of patients with stage II colon cancer - A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania. (2016) (24)
- Importance of patient reported outcome measures versus clinical outcomes for breast cancer patients evaluation on quality of care. (2016) (24)
- Effect of local therapy on locoregional recurrence in postmenopausal women with breast cancer in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial. (2013) (24)
- Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients – a large population-based study from 1990 to 2008 (2013) (23)
- Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy. (2016) (23)
- Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysis. (2013) (23)
- The role of allopurinol in human liver ischemia/reperfusion injury: a prospective randomized clinical trial. (2002) (23)
- Fluorescence-guided tumor detection with a novel anti-EpCAM targeted antibody fragment: Preclinical validation. (2019) (23)
- Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison (2018) (23)
- Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast Cancer. (2019) (22)
- Reduced Liver Uptake of Arterially Infused Melphalan during Retrograde Rat Liver Perfusion with Unaffected Liver Tumor Uptake (2002) (22)
- Combined expression of the non-receptor protein tyrosine kinases FAK and Src in primary colorectal cancer is associated with tumor recurrence and metastasis formation. (2008) (22)
- Interim analysis on survival data: its potential bias and how to repair it (2005) (22)
- A morphometrical analysis of lymph node responses to tumors of different immunogenicity. (1978) (22)
- Identification of a Quantitative MINT Locus Methylation Profile Predicting Local Regional Recurrence of Rectal Cancer (2010) (22)
- Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients. (2014) (22)
- Immunohistochemical detection of melphalan-DNA adducts in colon cancer cells in vitro and human colorectal liver tumours in vivo. (2004) (21)
- Cost-effectiveness of a short stay admission programme for breast cancer surgery (2010) (21)
- Melphalan Antitumor Efficacy and Hepatotoxicity: The Effect of Variable Infusion Duration in the Hepatic Artery (2003) (21)
- p53 expression in human rectal tissue after radiotherapy: upregulation in normal mucosa versus functional loss in rectal carcinomas. (2002) (21)
- T-cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. I. Significant bispecific lysis of syngeneic colon carcinoma CC531 is critically dependent on prolonged preactivation of effector T-lymphocytes by immobilized anti-T-cell receptor antibody. (1992) (21)
- Coagulopathy following major liver resection: the effect of rBPI21 and the role of decreased synthesis of regulating proteins by the liver. (2001) (20)
- Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer (2017) (20)
- The clinical prognostic value of molecular intrinsic tumor subtypes in older breast cancer patients: A FOCUS study analysis (2016) (20)
- Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion. (1997) (20)
- Continuous measurement of leakage during isolated liver perfusion with a radiotracer. (1987) (20)
- Stromal Targets for Fluorescent-Guided Oncologic Surgery (2015) (20)
- The effect of aspirin and nonsteroidal anti-inflammatory drug use after diagnosis on survival of oesophageal cancer patients (2016) (20)
- Toward optical guidance during endoscopic ultrasound-guided fine needle aspirations of pancreatic masses using single fiber reflectance spectroscopy: a feasibility study (2017) (20)
- Adjuvant chemotherapy in node negative breast cancer: patterns of use and oncologists' preferences. (2000) (20)
- The effect of different routes of administration of 5-fluorouracil on thymidylate synthase inhibition in the rat. (1995) (20)
- Role of NK cells in adoptive immunotherapy of metastatic colorectal cancer in a syngeneic rat model (2001) (19)
- Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer (2008) (19)
- Sialyl Lewis X Expression and Lymphatic Microvessel Density in Primary Tumors of Node-negative Colorectal Cancer Patients Predict Disease Recurrence (2008) (19)
- HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2. (2017) (19)
- Primary pheochromocytoma extending into the right atrium: report of a case and review of the literature. (2001) (19)
- In vivo isolated liver perfusion technique in a rat hepatic metastasis model: 5-fluorouracil concentrations in tumor tissue. (1988) (19)
- Long-Term Follow-Up of the Intergroup Exemestane Study. (2017) (18)
- Selection of optimal molecular targets for tumor-specific imaging in pancreatic ductal adenocarcinoma (2017) (18)
- The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis (2017) (18)
- Four‐color staining combining fluorescence and brightfield microscopy for simultaneous immune cell phenotyping and localization in tumor tissue sections (2005) (18)
- No association between metformin use and survival in patients with pancreatic cancer (2017) (18)
- Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial. (2019) (18)
- Disqualification of Neoadjuvant Rectal Score Based on Data of 6596 Patients From the Netherlands Cancer Registry. (2019) (18)
- Quality assurance in surgical oncology: The tale of the Dutch Rectal Cancer TME trial (2008) (18)
- Validation of full-field optical coherence tomography in distinguishing malignant and benign tissue in resected pancreatic cancer specimens (2017) (18)
- External radiotherapy and extrahepatic bile duct cancer. (1991) (17)
- Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma. (2010) (17)
- Isolated hepatic perfusion with oxaliplatin combined with 100 mg melphalan in patients with metastases confined to the liver: A phase I study. (2014) (17)
- Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine (2017) (17)
- Costs of different follow-up strategies in early breast cancer: a review of the literature. (2012) (17)
- T cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. II. Syngeneic colon carcinoma CC531 is efficiently killed by retargeted cytotoxic T lymphocytes in vitro despite limited lysis in 51Cr release assays. (1993) (17)
- Treatment Strategies and Survival of Older Breast Cancer Patients – An International Comparison between the Netherlands and Ireland (2015) (17)
- Isolated (hypoxic) hepatic perfusion with high-dose chemotherapy in patients with unresectable liver metastases of uveal melanoma: results from two experienced centres (2016) (17)
- Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer. (2010) (17)
- Therapeutic strategies in gastric cancer. (2003) (17)
- Age-dependent clinical prognostic value of histone modifications in colorectal cancer. (2015) (16)
- Ganciclovir nucleotides accumulate in mitochondria of rat liver cells expressing the herpes simplex virus thymidine kinase gene (2003) (16)
- Management of primary metastatic breast cancer in elderly patients--an international comparison of oncogeriatric versus standard care. (2014) (16)
- Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial. (2020) (16)
- Delivery of anticancer drugs via isolated hepatic perfusion: a promising strategy in the treatment of irresectable liver metastases? (1998) (16)
- Treatment and Survival of Patients with Colon Cancer Aged 80 Years and Older: A EURECCA International Comparison. (2018) (16)
- Potentiation of the cytostatic effect of melphalan on colorectal cancer hepatic metastases by infusion of buthionine sulfoximine (BSO) in the rat Enhanced tumor glutathione depletion by infusion of BSO in the hepatic artery (1999) (15)
- Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer. (2012) (15)
- Acute‐phase response patterns in isolated hepatic perfusion with tumour necrosis factor α (TNF‐α) and melphalan in patients with colorectal liver metastases (1999) (15)
- Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study. (2021) (15)
- Ten-year results of a randomized trial evaluating prolonged low-dose adjuvant chemotherapy in node-positive breast cancer: a joint European Organization for Research and Treatment of Cancer-Dutch Breast Cancer Working Party Study. Cooperating Investigators. (1995) (15)
- An analysis on the effect of blood transfusion on recurrence and survival in patients undergoing extended lymphadenectomy for colorectal cancer. (1994) (15)
- Are pathological high-risk features in locally advanced rectal cancer a useful selection tool for adjuvant chemotherapy? (2018) (15)
- Lack of glutathione conjugation of melphalan in the isolated in situ liver perfusion in humans. (1996) (15)
- Translational optical imaging in diagnosis and treatment of cancer. (2012) (15)
- A patient-centred instrument for assessment of quality of breast cancer care: results of a pilot questionnaire (2010) (15)
- Extended lymph node dissection for gastric cancer from a European perspective (2011) (14)
- The influence of insulin‐like Growth Factor‐1‐Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysis (2016) (14)
- Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells (2017) (14)
- Detailed examination of lymph nodes improves prognostication in colorectal cancer (2010) (14)
- Intraoperative Identification of a Normal Pituitary Gland and an Adenoma Using Near-Infrared Fluorescence Imaging and Low-Dose Indocyanine Green (2016) (14)
- Heterogeneity in disease free survival between centers: lessons learned from an EORTC breast cancer trial (2006) (14)
- Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery (2017) (14)
- Selection of optimal molecular targets for tumor-specific imaging in pancreatic ductal adenocarcinoma. (2017) (13)
- Treatment of liver metastases of colorectal cancer. (2005) (13)
- Survival and relapse free period of 2926 unselected older breast cancer patients: a FOCUS cohort study. (2015) (13)
- Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer (2014) (13)
- Whole body optical imaging in small animals and its translation to the clinic: intra-operative optical imaging guided surgery. (2009) (13)
- Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs). (2017) (13)
- Metastases of colorectal carcinoma: comparison of soft- and hard-copy helical CT interpretation. (2003) (12)
- Patterns of axillary staging and management in clinically node positive breast cancer patients treated with neoadjuvant systemic therapy: Results of a survey amongst breast cancer specialists. (2019) (12)
- In vitro schedule-dependent interaction between melphalan and oxaliplatin in human colorectal cancer cell lines. (2011) (12)
- Quantitative assessment of lymph vascular space invasion (LVSI) provides important prognostic information in node-negative breast cancer. (2013) (12)
- A prospective comparison of younger and older patients' preferences for breast-conserving surgery versus mastectomy in early breast cancer. (2017) (12)
- Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States (2020) (12)
- An experimental minimally invasive perfusion technique for the treatment of liver metastases. (2003) (12)
- Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer (2018) (12)
- Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy (2018) (12)
- Effects of regional lymphadenectomy and adjuvant chemotherapy on metastasis and survival in rodent tumour models. (1977) (12)
- Comparison of inversion-recovery gradient- and spin-echo and fast spin-echo techniques in the detection and characterization of liver lesions. (1998) (11)
- Improving treatment outcome for gastric cancer: the role of surgery and adjuvant therapy. (2003) (11)
- Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials. (2020) (11)
- Common variables in European pancreatic cancer registries: The introduction of the EURECCA pancreatic cancer project. (2016) (11)
- The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper. (2019) (11)
- Reliability of Self‐reported Treatment Data by Patients With Breast Cancer Compared With Medical Record Data (2017) (11)
- Patients' opinions on quality of care before and after implementation of a short stay programme following breast cancer surgery. (2010) (11)
- Clinical translation and implementation of optical imaging agents for precision image-guided cancer surgery (2020) (11)
- Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients. (2015) (10)
- Resection for gastric cancer in the community. (2005) (10)
- Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver. (2016) (10)
- Quantitative Whole Slide Assessment of Tumor-Infiltrating CD8-Positive Lymphocytes in ER-Positive Breast Cancer in Relation to Clinical Outcome (2020) (10)
- The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis (2016) (10)
- Surgical treatment of gastric cancer: anatomical borders and dissection of lymph nodes. (1998) (10)
- Promoter methylation and mRNA expression of HLA-G in relation to HLA-G protein expression in colorectal cancer. (2016) (10)
- Novel avenues in immunotherapies for colorectal cancer (2016) (10)
- Major liver resection results in a changed plasma amino acid pattern as reflected by a decreased Fischer ratio which improves by bactericidal/permeability increasing protein. (2001) (10)
- The Essentials of Locoregional Control in the Treatment of Gastric Cancer (2006) (10)
- Do Rectal Cancer Patients with PIK3CA Mutations Benefit from Preoperative Radiotherapy with Regard to Local Recurrences? (2010) (9)
- Patterns of Local Recurrence in Rectal Cancer: A Single-Center Experience (2009) (9)
- Gadolinium-DTPA enhanced MR imaging of intravenous extension of adrenocortical carcinoma. (1988) (9)
- Optimal surgery for advanced gastric cancer (2009) (9)
- T‐Cell Retargeting Using Bispecific Monoclonal Antibodies in a Rat Colon Carcinoma Model: IV. Tumor Neutralization in Winn Type Assays (1993) (9)
- Selective avoidance of postoperative locoregional radiotherapy in breast cancer seems to be justified. (1997) (9)
- Quality assurance of surgery in gastric and rectal cancer. (2004) (8)
- Fluorescence lifetime imaging to differentiate bound from unbound ICG-cRGD both in vitro and in vivo (2015) (8)
- Surgical Treatment for Unexplained Severe Pain of the Thyroid Gland: Report of Three Cases and Concise Review of the Literature (2011) (8)
- Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: A Dutch TEAM trial analysis (2015) (8)
- Neoadjuvant chemotherapy for early breast cancer (2009) (8)
- Effect of preoperative treatment strategies on the outcome of patients with clinical T3, non-metastasized rectal cancer: A comparison between Dutch and Canadian expert centers. (2015) (8)
- Internal biliary drainage, parenteral nutrition, and variation in the total parenteral nutrition feeding solutions: influence on the healing of colon anastomosis in jaundiced rats. (1990) (8)
- NK cells modulate MHC class I expression on tumor cells and their susceptibility to lysis. (2000) (8)
- Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial (2018) (8)
- Treatment strategies and survival outcomes in older women with breast cancer: A comparative study between the FOCUS cohort and Nottingham cohort. (2018) (8)
- Acute-phase response patterns in isolated hepatic perfusion with tumour necrosis factor alpha (TNF-alpha) and melphalan in patients with colorectal liver metastases. (1999) (8)
- Is it time for watchful waiting for rectal cancer? (2015) (8)
- Report of the Eleventh International Symposium of the Foundation for Promotion of Cancer Research: Basic and Clinical Research in Gastric Cancer. (1998) (8)
- Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer. (2018) (8)
- A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor‐Positive Advanced Breast Cancer (2017) (8)
- Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials. (2019) (8)
- The development of a bi-specific anti-CD161A x anti-tumor antibody for rat NK cell targeting. (1999) (7)
- A dual-labeled cRGD-based PET/optical tracer for pre-operative staging and intraoperative treatment of colorectal cancer. (2018) (7)
- Can adjuvant chemoradiotherapy replace extended lymph node dissection in gastric cancer? (2012) (7)
- 70-Gene Signature in Early-Stage Breast Cancer. (2016) (7)
- Time trends of short-term mortality for octogenarians undergoing a colorectal resection in North Europe. (2019) (7)
- Hepatic metastases: comparative study of diagnostic ultrasound, CT, nuclear scintigraphy and laboratory tests. (1991) (7)
- Discordance between IHC and ERBB2 mRNA to Determine HER2 Low Status for Breast Cancer. (2022) (7)
- Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapy. (2012) (7)
- Should patients with medullary thyroid carcinoma undergo extensive lymph node (re)operation to improve long-term survival? (1992) (7)
- Towards gene therapy for colorectal liver metastases. (1998) (7)
- Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial (2018) (7)
- Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial (2022) (7)
- Largely varying patterns and trends of primary cancer-directed resection for gastric carcinoma with synchronous distant metastasis in Europe and the US: a population-based study calling for further standardization of care (2021) (6)
- Quality of Life After Curative Resection for Rectal Cancer in Patients Treated With Adjuvant Chemotherapy Compared With Observation: Results of the Randomized Phase III SCRIPT Trial (2019) (6)
- Quality Assurance in Rectal Cancer Treatment (2012) (6)
- Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial (2020) (6)
- Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials (2022) (6)
- A detailed report of the resource use and costs associated with implementation of a short stay programme for breast cancer surgery (2015) (6)
- Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer. (2016) (5)
- Navigating surgical fluorescence cameras using near-infrared optical tracking (2018) (5)
- Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer (2017) (5)
- Locoregional Failure During and After Short-course Radiotherapy followed by Chemotherapy and Surgery Compared to Long-course Chemoradiotherapy and Surgery - A Five-year Follow-up of the RAPIDO Trial. (2023) (5)
- No Excess Mortality in Patients Aged 50 Years and Older Who Received Treatment for Ductal Carcinoma In Situ of the Breast (2012) (5)
- Copy number alterations and allelic ratio in relation to recurrence of rectal cancer (2015) (5)
- Treatment strategies and overall survival for incurable metastatic colorectal cancer - A EURECCA international comparison including 21,196 patients from the Netherlands and Norway. (2020) (5)
- Current role of surgery and multimodal treatment in localized gastric cancer. (2008) (5)
- Breast cancer in the elderly: reducing the losses. (2013) (4)
- Adjuvant chemotherapy for rectal cancer - authors' reply. (2015) (4)
- Survival trends of patients with non‐metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates (2022) (4)
- Quality assurance and sustainability of cancer care: A European network is needed. (2018) (4)
- Can micrometastases be used to predict colon cancer prognosis? Hopes for the EnRoute+ study (2011) (4)
- Erratum to "Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial" [Radiother. Oncol. 147 (2020) 75-83]. (2020) (4)
- Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial (2021) (4)
- The population‐attributable fraction for time‐dependent exposures using dynamic prediction and landmarking (2019) (4)
- Considerations and restrictions for non-operative treatment of rectal cancer in selected patients. (2007) (4)
- Gastric cancer: staging and surgery. (2002) (4)
- Feasibility of tailored follow-up for patients with early breast cancer. (2014) (4)
- One-year excess mortality and treatment in surgically treated patients with colorectal cancer: A EURECCA European comparison. (2021) (3)
- [Intraoperative imaging using fluorescence]. (2012) (3)
- Quality of Life Is Associated With Survival in Patients With Gastric Cancer: Results From the Randomized CRITICS Trial. (2022) (3)
- The EORTC-Breast Cancer Cooperative Group clinical research programme in early breast cancer. EORTC-BCCG. (1998) (3)
- T-cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model: III. Activation of resting T cells and tumor neutralization induced by bispecific antibodies. (1993) (3)
- Preoperative chemotherapy in operable breast cancer. The influence of timing FEC in relation to surgery. (1993) (3)
- Microsatellite instability in rectal cancer: what does it mean? A study of two randomized trials and a systematic review of the literature (2022) (3)
- Quality assurance in melanoma care: The EU-MELACARE study. (2018) (3)
- CEA, EpCAM, αvβ6 and uPAR Expression in Rectal Cancer Patients with a Pathological Complete Response after Neoadjuvant Therapy (2021) (3)
- A method for semi-automated image analysis of HLA class I tumour epithelium expression in rectal cancer (2019) (3)
- Network-Based Biomarkers Enable Cross-Disease Biomarker Discovery (2018) (3)
- Prospective comparative study of ultrasound, CT-scan, scintigraphy and laboratory tests to detect hepatic metastases. (1991) (3)
- Radiochemotherapy in rectal cancer: the role of oxaliplatin (2003) (3)
- The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival (2021) (3)
- The survival gap between young and older patients after surgical resection for colorectal cancer remains largely based on early mortality: A EURECCA comparison of four European countries. (2022) (3)
- Management of colorectal cancer. (1986) (3)
- Surgery: palliative primary tumour resection in mCRC-debate continues. (2015) (2)
- Microsatellite instability and sex differences in resectable gastric cancer - A pooled analysis of three European cohorts. (2022) (2)
- Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy? (2013) (2)
- [The value of follow-up studies after surgery of carcinoma of the large intestine]. (1987) (2)
- Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES (2017) (2)
- The staging of hepatic metastases arising from colorectal cancer. (1986) (2)
- Time to focus on the quality of colon-cancer surgery. (2008) (2)
- An international comparison of treatment and short-term overall survival for older patients with pancreatic cancer. (2019) (2)
- Intra-Tumoral Genomic Heterogeneity in Rectal Cancer: Mutational Status Is Dependent on Preoperative Biopsy Depth and Location (2020) (2)
- Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial (2013) (2)
- Gene expression profiling reveals two separate mechanisms regulating apoptosis in rectal carcinomas in vivo (2007) (2)
- Treatment of liver metastases of colorectal cancer Ann Oncol 2005; 16 Suppl 2: ii144-ii149. (2006) (2)
- Endogenous natural killer cells do not play a role in antitumor effects induced by interleukin-2 in a syngeneic rat colon tumor model (2000) (2)
- What is there to learn for watch-and-wait in rectal cancer? (2017) (2)
- Reply to: Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommnendation to optimize the performance. (2019) (2)
- Adjuvant chemotherapy: theoretical considerations and model studies. (1979) (1)
- Early identification of non-responding locally advanced breast tumors receiving neoadjuvant chemotherapy (2015) (1)
- Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study (2014) (1)
- European Society of Surgical Oncology's strategy for clinical research: Paving the way for a culture of research in cancer surgery. (2019) (1)
- The surgical treatment of gastric cancer with special reference to systematic lymph node dissection. (1991) (1)
- Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study (2021) (1)
- Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor–Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial (2022) (1)
- Interpreting the RAPIDO trial: factors to consider - Authors' reply. (2021) (1)
- Introduction to the surgical treatment of gastric cancer: anatomical borders and dissection of lymph nodes. (1998) (1)
- Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial (2021) (1)
- Abstract GS5-10: Utility of the 70-gene MammaPrint test for prediction of extended endocrine therapy benefit in patients with early-stage breast cancer in the IDEAL Trial (2023) (1)
- High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients (2014) (1)
- Image-guided surgery using near-infrared fluorescent light: from bench to bedside (2015) (1)
- The EORTC strategy for the early 2000's. (2000) (1)
- Results of a comparison between European countries for esophagectomy and gastrectomy: Initiative for a European upper GI audit (EURECCA Upper GI). (2012) (1)
- Effects of tamoxifen and exemestane on cognitive function in postmenopausal patients with breast cancer (2023) (1)
- Adjuvant chemotherapy for patients with rectal cancer? (2014) (1)
- Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study (2014) (0)
- NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study (2012) (0)
- Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine (2017) (0)
- Perioperative chemotherapy in patients with node-negative postmenopausal breast cancer. (2002) (0)
- Authors' reply: Urinary dysfunction after rectal cancer treatment is mainly caused by surgery (Br J Surg 2008; 95: 1020–1028) (2008) (0)
- Accomplishments in 2007 in the management of localized gastric cancer. (2008) (0)
- Copy number alterations and allelic ratio in relation to recurrence of rectal cancer (2015) (0)
- Authors' reply: Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery (Br J Surg 2009; 96: 1066–1075) (2010) (0)
- Attitudes towards detection and management of hepatic metastases in the Western world. (1988) (0)
- [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma]. (2004) (0)
- Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial. (2023) (0)
- Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial (2023) (0)
- Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer (2012) (0)
- Abstract P2-11-10: Validation of the Breast Cancer Index (BCI) prognostic models optimized for late distant recurrence in postmenopausal women with early-stage HR+ breast cancer in the TEAM trial (2023) (0)
- The effect of preoperative chemotherapy on lymph node yield in gastric cancer. (2011) (0)
- Results of completed clinical trials for gastric cancer. (1995) (0)
- Improved selection of cortical ovarian strips for autotransplantation of ovarian tissue using full-field optical coherence tomography (FFOCT) (2016) (0)
- Stage Migration in Gastric Cancer: Its Influence on Survival Rates (1999) (0)
- [Worse prognosis for older breast cancer patients]. (2012) (0)
- Conditional survival nomogram after an R0 resection for gastric cancer. (2011) (0)
- DNA methylation of apoptosis genes in rectal cancer predicts patient survival and tumor recurrence (2014) (0)
- Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial. (2018) (0)
- Predictive performance of breast cancer index (BCI) and clinical treatment score post-5 years (CTS5) in the IDEAL study. (2022) (0)
- 290PCLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF P53-POSITIVE BREAST CANCER STAGE I IN RUSSIAN AND DUTCH POPULATIONS. (2014) (0)
- Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patients. (2012) (0)
- [Sentinel node metastasis in the case of colorectal cancer. No role for sentinel node biopsy at present]. (2005) (0)
- Chromatin status of apoptosis genes correlates with sensitivity to chemo-, immune- and radiation therapy in colorectal cancer cell lines (2014) (0)
- Prognostic and predictable value of COX2 expression in Russian women with stage I breast cancer. (2014) (0)
- Abstract 1727: CD8+ T cells in the invasive margin combined with FOXP3+ T cells in the tumor center significantly associate with survival in resectable gastric cancer, a post-hoc analysis of the Dutch D1/D2 trial (2022) (0)
- Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study (2021) (0)
- Cutaneous and intra-abdominal abscess formation in rats following radio frequency [corrected] ablation of liver tumors in combination with celecoxib treatment. (2006) (0)
- Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer (2014) (0)
- [The treatment of patients with gastric carcinoma based on the results of Dutch studies]. (2005) (0)
- A forme fruste of von Hippel-Lindau disease: a combination of adrenal pheochromocytoma and ipsilateral renal cell carcinoma--a case report. (1989) (0)
- Image-guided surgery using fluorescence: road to clinical translation of novel probes (2016) (0)
- [Methods of detection and treatment of liver metastases in the Western world]. (1987) (0)
- [Extensive lymph node dissection in stomach cancer? Initial results of the Dutch Stomach Cancer Study]. (1996) (0)
- Highlights from the seventh European Multidisciplinary Colorectal Cancer Congress (EMCCC) 2014 (2015) (0)
- Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer (2022) (0)
- Node negative colorectal cancer patients: assesment of high-risk features on recurrence. (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Cornelis J. H. Van De Velde?
Cornelis J. H. Van De Velde is affiliated with the following schools:
